Positive association between striatal serotonin level and abnormal involuntary movements in chronic L-DOPA-treated hemiparkinsonian rats

Positive association between striatal serotonin level and abnormal involuntary movements in chronic L-DOPA-treated hemiparkinsonian rats
复制标题

DOI:
10.1016/j.brainresbull.2010.12.006
复制
发表时间:
2011-02-01
影响因子:
3.8
通讯作者:
Koh, Hyun C.
Koh, Hyun C.
中科院分区:
医学3区
文献类型:
--
作者:
Gil, Suk J.;Park, Chang H.;Koh, Hyun C.

文献摘要

被引文献

相似文献

虽然左旋多巴代表了帕金森病的标准治疗,但长期治疗可能会受到左旋多巴诱导的运动障碍(LID)的影响,伴随运动反应性的不利波动和进行性失控。在这里,我们表明,在大鼠与6-羟基多巴胺诱导的病变的正中前脑束,LID与5-HT水平。用左旋多巴(6 mg/kg)和苄丝肼(15 mg/kg)连续3周诱发大鼠异常不自主运动(AIMS),结果表明,慢性左旋多巴治疗后,大鼠损伤侧纹状体多巴胺(DA)和5-羟色胺(5-HT)水平明显改变。纹状体DA和5-羟色胺(5-HT)水平呈负相关,AIM与DA水平呈强正相关,与5-HT水平呈负相关。与其他AIM亚型相比,轴向AIM与DA和5-HT水平的相关性更强,而运动性AIM则完全没有显着相关性。此外,纹状体5-HT与AIM比纹状体DA水平更强(负)相关。这些结果表明,5-HT有助于LID和纹状体DA(积极)和5-HT(消极)影响LID的严重程度。我们认为通过策略性地改变5-羟色胺系统可能减轻长期左旋多巴治疗的不良反应。(C)2010年爱思唯尔公司All rights reserved.
Although L-DOPA represents the standard of care in Parkinson's disease, long-term treatment may be compromised by L-DOPA-induced dyskinesia (LID), with adverse fluctuations in motor responsiveness and progressive loss of control. Here we show that in rats with 6-hydroxydopamine-induced lesions of the median forebrain bundle, LID correlates with 5-HT levels. Rats were treated with L-DOPA (6 mg/kg) and benserazide (15 mg/kg) daily for 3 weeks to induce the development of abnormal involuntary movements (AIMS).After this chronic L-DOPA treatment, the lesion side of the rats displayed significant changes in striatal dopamine (DA) and 5-HT levels. Striatal DA and 5-hydroxytryptamine (5-HT) levels were inversely correlated, and AIMs were strongly positively correlated DA levels and negatively correlated with 5-HT levels. Axial AIMs were more strongly correlated with DA and 5-HT levels than were the other AIMs subtypes, while locomotive AIMs showed no significant correlation at all. In addition, striatal 5-HT was more strongly (negatively) correlated with the AIMs than striatal DA levels. These results demonstrate that 5-HT contributes to LID and that both striata DA (positively) and 5-HT(negatively) affect the severity of LID. We suggest that by strategic modification of the serotonin system it may be posible to attenuate the adverse effect of chronic L-DOPA therapy. (C) 2010 Elsevier Inc. All rights reserved.